MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $95,000 | +43.9% | 3,699 | +6.0% | 0.00% | 0.0% |
| Q1 2017 | $66,000 | +560.0% | 3,489 | +481.5% | 0.00% | – |
| Q4 2016 | $10,000 | +25.0% | 600 | +50.0% | 0.00% | – |
| Q3 2016 | $8,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | -14.3% | 400 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | -39.1% | 400 | -27.3% | 0.00% | -100.0% |
| Q4 2015 | $23,000 | -94.4% | 550 | -95.0% | 0.00% | -92.9% |
| Q3 2015 | $410,000 | +8.2% | 10,976 | -1.8% | 0.01% | +16.7% |
| Q2 2015 | $379,000 | -5.7% | 11,174 | -1.8% | 0.01% | -7.7% |
| Q1 2015 | $402,000 | -1.0% | 11,377 | -4.8% | 0.01% | 0.0% |
| Q4 2014 | $406,000 | +13433.3% | 11,949 | +11849.0% | 0.01% | – |
| Q3 2014 | $3,000 | -50.0% | 100 | -66.0% | 0.00% | – |
| Q4 2013 | $6,000 | – | 294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,309,206 | $109,866,000 | 6.94% |
| SG Capital Management LLC | 604,159 | $20,058,000 | 3.66% |
| KESTREL INVESTMENT MANAGEMENT CORP | 232,975 | $7,735,000 | 3.57% |
| Broadfin Capital, LLC | 500,000 | $16,600,000 | 3.43% |
| Tieton Capital Management, LLC | 98,199 | $3,260,000 | 2.90% |
| SG Capital Management LLC | 350,000 | $11,620,000 | 2.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,852,064 | $94,689,000 | 1.66% |
| Broadfin Capital, LLC | 240,000 | $7,968,000 | 1.64% |
| Millrace Asset Group, Inc. | 58,302 | $1,936,000 | 1.63% |
| PURA VIDA INVESTMENTS, LLC | 300,000 | $9,960,000 | 1.42% |